Brief: Liminal BioSciences Reports First Quarter 2022 Results
10/05/2022 22:31
May 10 (Reuters) - Liminal BioSciences Inc LMNL.O :
* LIMINAL BIOSCIENCES REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND BUSINESS HIGHLIGHTS
* LIMINAL BIOSCIENCES - CASH WAS $61.2 MILLION AT MARCH 31,
2022
WHILE OUR WORKING CAPITAL, I.E., CURRENT ASSETS NET OF CURRENT
LIABILITIES, WAS $42.7 MILLION
* LIMINAL BIOSCIENCES INC - NET LOSS OF $11.2 MILLION DURING
QUARTER ENDED MARCH 31, 2022
Source text for Eikon: ID:nCNWgldQ8a
Further company coverage: LMNL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Liminal BioSciences
See all newsBrief: Liminal Biosciences Announces Completion Of The Plan Of Arrangement With Structured Alpha Lp
Brief: Liminal Biosciences Files Amended Schedule 13E-3 And Supplement To Management Information Circular
Brief: Liminal Biosciences Obtains Interim Order For Proposed Arrangement With Structured Alpha Lp
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy